MedPath

JAZZ PHARMACEUTICALS, INC.

JAZZ PHARMACEUTICALS, INC. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2003-01-01
Employees
501
Market Cap
-
Website
http://www.jazzpharma.com

Clinical Trials

31

Active:27
Completed:4

Trial Phases

1 Phases

Phase 1:13

Drug Approvals

7

FDA:7

Drug Approvals

Epidiolex

Approval Date
Mar 13, 2024
FDA

ZEPZELCA

Approval Date
Jul 28, 2023
FDA

Xyrem

Approval Date
Apr 25, 2023
FDA

XYWAV

Approval Date
Apr 25, 2023
FDA

DEFITELIO

Approval Date
Dec 7, 2022
FDA

Rylaze

Approval Date
Nov 18, 2022
FDA

VYXEOS

Approval Date
Sep 27, 2022
FDA

Clinical Trials

Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials

Phase 1
13 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.